We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.39%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$9.65B
AUM Growth
+$414M
(+4.5%)
Cap. Flow
+$77.2M
Cap. Flow
% of AUM
0.8%
Top 10 Holdings %
Top 10 Hldgs %
20.18%
Holding
1,150
New
121
Increased
363
Reduced
495
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$53.4M |
| 2 |
Occidental Petroleum
OXY
|
+$38M |
| 3 |
Capital One
COF
|
+$36.7M |
| 4 |
Elevance Health
ELV
|
+$27.1M |
| 5 |
Kroger
KR
|
+$20.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Align Technology
ALGN
|
+$43.2M |
| 2 |
Microsoft
MSFT
|
+$36.6M |
| 3 |
Qualcomm
QCOM
|
+$34.8M |
| 4 |
Mastercard
MA
|
+$33.6M |
| 5 |
Merck
MRK
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.04% |
| 2 | Healthcare | 14.84% |
| 3 | Consumer Discretionary | 14.57% |
| 4 | Financials | 13.21% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Barrett Business Services
BBSI
$982M
| $4.76M | 0.05% |
363,220
-11,352
| -3% | -$155K |
|
|
MTOR
352
DELISTED
MERITOR, Inc.
MTOR
| $4.75M | 0.05% |
226,637
-574,754
| -72% | -$12.9M |
|
|
CSR
353
Centerspace
CSR
$941M
| $4.73M | 0.05% |
72,602
-8,831
| -11% | -$619K |
|
354
SPX Corp
SPXC
$9.98B
| $4.71M | 0.05% |
101,614
-5,458
| -5% | -$230K |
|
355
National Health Investors
NHI
$3.69B
| $4.67M | 0.05% |
77,485
-3,424
| -4% | -$211K |
|
356
Comtech Telecommunications
CMTL
$50.9M
| $4.66M | 0.05% |
333,057
+258,505
| +347% | +$4.13M |
|
357
Cooper-Standard Automotive
CPS
$514M
| $4.65M | 0.05% |
352,242
-18,051
| -5% | -$251K |
|
358
International Seaways
INSW
$4.71B
| $4.61M | 0.05% |
315,439
+4,104
| +1% | +$68.5K |
|
359
AT&T
T
$159B
| $4.61M | 0.05% |
214,043
+105,671
| +98% | +$2.36M |
|
|
PLAN
360
DELISTED
Anaplan, Inc.
PLAN
| $4.59M | 0.05% |
73,345
+7,319
| +11% | +$377K |
|
361
Q32 Bio
QTTB
$462M
| $4.59M | 0.05% |
23,813
+6,564
| +38% | +$1.47M |
|
|
BNFT
362
DELISTED
Benefitfocus, Inc.
BNFT
| $4.58M | 0.05% |
408,940
+279,114
| +215% | +$3.06M |
|
363
Crocs
CROX
$6.14B
| $4.56M | 0.05% |
+106,797
| New | +$4.13M |
|
364
Quanex
NX
$818M
| $4.55M | 0.05% |
246,520
-14,264
| -5% | -$227K |
|
|
CIVI
365
DELISTED
Civitas Resources
CIVI
| $4.53M | 0.05% |
241,029
-28,238
| -10% | -$529K |
|
366
Arlo Technologies
ARLO
$1.57B
| $4.53M | 0.05% |
860,671
-232,764
| -21% | -$1.12M |
|
367
The Bancorp
TBBK
$2.7B
| $4.51M | 0.05% |
521,896
+104,836
| +25% | +$963K |
|
|
SPPI
368
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $4.49M | 0.05% |
1,099,695
+241,448
| +28% | +$918K |
|
369
Gogo Inc
GOGO
$559M
| $4.49M | 0.05% |
485,537
-1,270,045
| -72% | -$6.94M |
|
|
JBGS
370
JBG SMITH
JBGS
$820M
| $4.44M | 0.05% |
+166,130
| New | +$4.66M |
|
|
XENT
371
DELISTED
Intersect ENT, Inc
XENT
| $4.42M | 0.05% |
271,007
-11,783
| -4% | -$213K |
|
372
Dine Brands
DIN
$457M
| $4.38M | 0.05% |
80,196
+20,698
| +35% | +$1.05M |
|
|
AAMI
373
Acadian Asset Management
AAMI
$2.99B
| $4.34M | 0.05% |
336,318
+317,345
| +1,673% | +$4.18M |
|
374
Vanda Pharmaceuticals
VNDA
$312M
| $4.33M | 0.04% |
+448,144
| New | +$4.79M |
|
375
Axos Financial
AX
$5.6B
| $4.27M | 0.04% |
183,059
+140,973
| +335% | +$3.22M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2020 Portfolio in Review
As of Q3 2020, Jacobs Levy Equity Management held 1,150 positions worth $9.65B, up 4.5% from $9.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jacobs Levy Equity Management's Q3 2020 filing shows 121 new, 363 increased, 495 reduced and 137 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M. The largest sale was Align Technology, an estimated $43.2M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q3 2020 buy was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M.
- Jacobs Levy Equity Management added most to Lowe's Companies in Q3 2020, an estimated $53.4M increase.
- Jacobs Levy Equity Management's biggest Q3 2020 reduction was Align Technology, cutting an estimated $43.2M.
- Jacobs Levy Equity Management fully exited Cloudera, Inc. in Q3 2020, selling an estimated $17.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 20% of its $9.65B portfolio in Q3 2020.
- Jacobs Levy Equity Management opened 121 new positions and closed 137 in Q3 2020.
- Jacobs Levy Equity Management's portfolio value rose 4.5% quarter-over-quarter to $9.65B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2020, filed 16 Nov 2020.